Reneo Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Reneo Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Reneo Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Reneo Pharmaceuticals by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $13k | 7.7k | 1.70 |
2024-06-30 | $12k | 7.9k | 1.51 |
2024-03-31 | $25k | 15k | 1.66 |
2023-12-31 | $26k | 16k | 1.60 |
2023-09-30 | $65k | 8.6k | 7.62 |
2023-06-30 | $51k | 7.7k | 6.56 |
2023-03-31 | $118k | 20k | 5.97 |
2022-12-31 | $45k | 20k | 2.31 |
2022-03-31 | $12k | 4.1k | 2.94 |
2021-12-31 | $21k | 2.4k | 8.67 |
Top funds holding Reneo Pharmaceuticals
View all funds holding Reneo Pharmaceuticals